Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona
Quick facts
Marketed products
- azelastine hydrochloride 0.05% · Allergy/Immunology
Azelastine hydrochloride is a selective H1-receptor antagonist that blocks histamine-mediated allergic responses in the nasal mucosa.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona portfolio CI brief
- Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona pipeline updates RSS
Frequently asked questions about Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona
What are Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona's marketed drugs?
Top marketed products include azelastine hydrochloride 0.05%.
Related
- azelastine hydrochloride 0.05% · Allergy/Immunology
- Sector hub: All tracked pharma companies